All payments made in the preview are in test mode. Read more
Sign in
Back to Atlas
BSemi-durableNootropic/stimulant caution
CMP-0187
Research

Dihexa

Nootropic / Neuroplasticity

Synaptogenesis and cognitive enhancement positioning

Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type
Peptide mimetic
Primary mechanism
HGF/c-Met pathway modulation
Primary market use
Cognition

Pharmacology

Molecular weight (Da)
504.7
Oral bioavailability
Likely oral; human BA unknown
Half-life
~5–60 min parent peptide; analogs may be longer
Route tags
Oral
Evidence level
Preclinical
Clinical status
Research
Value-for-money score
5 / 10

Reported protocol signal

Topical: • 20 mg/ml twice a day (Dr. Seeds) • 8-45 mg daily (Jay Campbell) • 10-20 mg to inner forearms daily, rub in until absorbed (Tailor Made Compounding Catalog) Oral: • 1-2 mg daily (Tailor Made Compounding Catalog)

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

High-interest experimental nootropic

Educational and organizational assistant matrix. Not medical advice.

BioChrysalis Atlas is an educational, organizational, and tracking asset. It does not provide medical advice, diagnosis, treatment, prescriptions, or individualized dosing instructions. Compound profiles, protocol notes, and dosage fields summarize publicly discussed or source-listed reference patterns and are not recommendations. Consult a qualified healthcare professional before starting, stopping, or modifying any compound, medication, or supplement protocol.

© BioChrysalis · Evolve · Ascend · Transcend